Skip to main content
. 2023 Nov 28;9(12):e22843. doi: 10.1016/j.heliyon.2023.e22843

Table 7.

Comparison of pharmacokinetic parameters of withanoside IV concentration in blood plasma with Withania somnifera extracts.

Parameters WS-35
WS-2.5
LSM Difference ± SE 95% CI
P value
LSM ± SE LSM ± SE Lower Upper
AUC 0-inf 92.516 ± 14.344 11.345 ± 0.354 81.171 ± 14.202 50.489 111.852 0.00007
AUC 0-t 36.985 ± 2.808 6.989 ± 0.12 29.996 ± 2.777 23.996 35.996 <0.001
AUC ext 55.531 ± 12.136 4.357 ± 0.362 51.174 ± 12.049 25.145 77.204 0.00095
Clearance 2.635 ± 0.353 16.529 ± 0.442 −13.894 ± 0.398 −14.753 −13.035 <0.001
Cmax 7.231 ± 0.416 2.668 ± 0.041 4.563 ± 0.405 3.689 5.437 <0.001
Ke 0.1 ± 0.013 0.302 ± 0.014 −0.202 ± 0.014 −0.232 −0.172 <0.001
Lambda Z 0.1 ± 0.013 0.302 ± 0.014 −0.202 ± 0.014 −0.232 −0.172 <0.001
Mean Residence Time 12.907 ± 1.621 4.178 ± 0.231 8.729 ± 1.574 5.328 12.13 0.00009
t half 8.856 ± 1.152 2.425 ± 0.181 6.431 ± 1.109 4.035 8.827 0.00006
t max# 1.763 ± 0.068 1.571 ± 0.066 0.192 ± 0.106 −0.037 0.421 0.09342
Vz 27.669 ± 2.626 56.376 ± 2.463 −28.707 ± 3.221 −35.666 −21.748 <0.001

2 × 2 cross-over design using t-test.

#

2 × 2 cross-over design using Mann-Whitney test.